TCRT - Alaunos Therapeutics, Inc.
3.61
0.205 5.679%
Share volume: 25,767
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$3.40
0.21
0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 6.037 M | 4.678 M | 3.550 M | 2.120 M | 4.735 M | 3.724 M | |
| Current Assets | 6.037 M | 4.678 M | 3.550 M | 1.067 M | 3.738 M | 2.685 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.145 M | 2.463 M | 1.683 M | 319.000 K | 2.879 M | 1.938 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 97.000 K | |
| Other Assets | 0.000 | 0.000 | 0.000 | 1.053 M | 997.000 K | 942.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 6.037 M | 4.678 M | 3.550 M | 2.120 M | 4.735 M | 3.724 M | |
| Total liabilities | 1.240 M | 907.000 K | 826.000 K | 1.062 M | 1.074 M | 921.000 K | |
| Total current liabilities | 1.240 M | 907.000 K | 826.000 K | 1.062 M | 1.074 M | 921.000 K | |
| Accounts Payable | 597.000 K | 365.000 K | 458.000 K | 831.000 K | 809.000 K | 843.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.797 M | 3.771 M | 2.724 M | 1.058 M | 3.661 M | 2.803 M | |
| Common stock | 922.246 M | 922.348 M | 922.428 M | 922.577 M | 926.231 M | 926.532 M | |
| Retained earnings | -917.449 M | -918.577 M | -919.704 M | -921.519 M | -922.570 M | -923.729 M |